Literature DB >> 35014847

SILAC Phosphoproteomics Reveals Unique Signaling Circuits in CAR-T Cells and the Inhibition of B Cell-Activating Phosphorylation in Target Cells.

Alijah A Griffith1, Kenneth P Callahan1, Nathan Gordo King1, Qian Xiao2, Xiaolei Su2, Arthur R Salomon1.   

Abstract

Chimeric antigen receptor (CAR) is a single-pass transmembrane receptor designed to specifically target and eliminate cancers. While CARs prove highly efficacious against B cell malignancies, the intracellular signaling events which promote CAR T cell activity remain elusive. To gain further insight into both CAR T cell signaling and the potential signaling response of cells targeted by CAR, we analyzed phosphopeptides captured by two separate phosphoenrichment strategies from third generation CD19-CAR T cells cocultured with SILAC labeled Raji B cells by liquid chromatography-tandem mass spectrometry (LC-MS/MS). Here, we report that CD19-CAR T cells upregulated several key phosphorylation events also observed in canonical T cell receptor (TCR) signaling, while Raji B cells exhibited a significant decrease in B cell receptor-signaling related phosphorylation events in response to coculture. Our data suggest that CD19-CAR stimulation activates a mixture of unique CD19-CAR-specific signaling pathways and canonical TCR signaling, while global phosphorylation in Raji B cells is reduced after association with the CD19-CAR T cells.

Entities:  

Keywords:  SILAC cell coculture; Src SH2 superbinder; T cell signaling; chimeric antigen receptor; immunotherapy; tumor associated antigen

Mesh:

Substances:

Year:  2022        PMID: 35014847      PMCID: PMC8830406          DOI: 10.1021/acs.jproteome.1c00735

Source DB:  PubMed          Journal:  J Proteome Res        ISSN: 1535-3893            Impact factor:   4.466


  88 in total

1.  Residues Y429 and Y463 of the human CD5 are targeted by protein tyrosine kinases.

Authors:  J M Vilà; I Gimferrer; O Padilla; M Arman; L Places; M Simarro; J Vives; F Lozano
Journal:  Eur J Immunol       Date:  2001-04       Impact factor: 5.532

2.  Vav1 Regulates T-Cell Activation through a Feedback Mechanism and Crosstalk between the T-Cell Receptor and CD28.

Authors:  Ynes A Helou; Anna P Petrashen; Arthur R Salomon
Journal:  J Proteome Res       Date:  2015-06-16       Impact factor: 4.466

3.  The catalytic activity of the kinase ZAP-70 mediates basal signaling and negative feedback of the T cell receptor pathway.

Authors:  Hanna Sjölin Goodfellow; Maria P Frushicheva; Qinqin Ji; Arup K Chakraborty; Arthur Salomon; Arthur Weiss; Debra A Cheng; Theresa A Kadlecek; Aaron J Cantor; John Kuriyan
Journal:  Sci Signal       Date:  2015-05-19       Impact factor: 8.192

Review 4.  CAR T-cell therapy of solid tumors.

Authors:  Carmen S M Yong; Valerie Dardalhon; Christel Devaud; Naomi Taylor; Phillip K Darcy; Michael H Kershaw
Journal:  Immunol Cell Biol       Date:  2016-12-22       Impact factor: 5.126

Review 5.  Chimeric antigen receptor T-cell therapy - assessment and management of toxicities.

Authors:  Sattva S Neelapu; Sudhakar Tummala; Partow Kebriaei; William Wierda; Cristina Gutierrez; Frederick L Locke; Krishna V Komanduri; Yi Lin; Nitin Jain; Naval Daver; Jason Westin; Alison M Gulbis; Monica E Loghin; John F de Groot; Sherry Adkins; Suzanne E Davis; Katayoun Rezvani; Patrick Hwu; Elizabeth J Shpall
Journal:  Nat Rev Clin Oncol       Date:  2017-09-19       Impact factor: 66.675

6.  Mapping the Zap-70 phosphorylation sites on LAT (linker for activation of T cells) required for recruitment and activation of signalling proteins in T cells.

Authors:  P E Paz; S Wang; H Clarke; X Lu; D Stokoe; A Abo
Journal:  Biochem J       Date:  2001-06-01       Impact factor: 3.857

7.  PeptideDepot: flexible relational database for visual analysis of quantitative proteomic data and integration of existing protein information.

Authors:  Kebing Yu; Arthur R Salomon
Journal:  Proteomics       Date:  2009-12       Impact factor: 3.984

Review 8.  CAR T Cell Therapy in Acute Lymphoblastic Leukemia and Potential for Chronic Lymphocytic Leukemia.

Authors:  Nathan Singh; Noelle V Frey; Stephan A Grupp; Shannon L Maude
Journal:  Curr Treat Options Oncol       Date:  2016-06

Review 9.  An introduction to chimeric antigen receptor (CAR) T-cell immunotherapy for human cancer.

Authors:  Steven Feins; Weimin Kong; Erik F Williams; Michael C Milone; Joseph A Fraietta
Journal:  Am J Hematol       Date:  2019-02-18       Impact factor: 10.047

10.  4-1BB costimulation ameliorates T cell exhaustion induced by tonic signaling of chimeric antigen receptors.

Authors:  Adrienne H Long; Waleed M Haso; Jack F Shern; Kelsey M Wanhainen; Meera Murgai; Maria Ingaramo; Jillian P Smith; Alec J Walker; M Eric Kohler; Vikas R Venkateshwara; Rosandra N Kaplan; George H Patterson; Terry J Fry; Rimas J Orentas; Crystal L Mackall
Journal:  Nat Med       Date:  2015-05-04       Impact factor: 53.440

View more
  2 in total

1.  A Sensitive and Controlled Data-Independent Acquisition Method for Proteomic Analysis of Cell Therapies.

Authors:  Camille Lombard-Banek; Kerstin I Pohl; Edward J Kwee; John T Elliott; John E Schiel
Journal:  J Proteome Res       Date:  2022-04-11       Impact factor: 5.370

Review 2.  Single-Cell Proteomics: The Critical Role of Nanotechnology.

Authors:  Carlota Arias-Hidalgo; Pablo Juanes-Velasco; Alicia Landeira-Viñuela; Marina L García-Vaquero; Enrique Montalvillo; Rafael Góngora; Ángela-Patricia Hernández; Manuel Fuentes
Journal:  Int J Mol Sci       Date:  2022-06-16       Impact factor: 6.208

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.